Market Place
Sourcing Support
Cheplapharm places notes in a volume of €750m in challenging market environment
28 Apr 2023 //
PRESS RELEASE
Cheplapharm selects Generis’ CARA platform to unify clinical processes
20 Jan 2023 //
INDIANPHARMAPOST
Astellas Transfers 5 Products in Europe, Russia, CIS & Asia to Cheplapharm
16 Jun 2021 //
PRESS RELEASE
Atacand divestment to Cheplapharm in more than 70 countries completed
04 Jan 2021 //
PRESS RELEASE
AstraZeneca sells commercial rights to two drugs in $400 million deal
31 Oct 2020 //
REUTERS
LEO Pharma Sells Portfolio of Four Products to Cheplapharm
04 Sep 2020 //
BUSINESSWIRE
LEO Pharma Sells Portfolio of Four Products to Cheplapharm
03 Sep 2020 //
BUSINESSWIRE
LEO Pharma divests four medicines to Cheplapharm for $357m
31 Aug 2020 //
PHARMACEUTICAL TECHNOLOGY
LEO Pharma Sells Portfolio of Four Products to Cheplapharm
31 Aug 2020 //
BUSINESSWIRE
AstraZeneca offloads more Seroquel rights, this time to Cheplapharm for $42M
04 Dec 2019 //
FIERCE PHARMA
AstraZeneca sells European rights for schizophrenia drug to Cheplapharm
30 Oct 2019 //
REUTERS
As its oncology effort gathers steam, AstraZeneca sheds another legacy drug
03 Oct 2019 //
ENDPTS
AstraZeneca sells acid reflux drug rights to Germany`s Cheplapharm
02 Oct 2019 //
REUTERS
Clinigen Signs Exclusive Distribution Agreement with CHEPLAPHARM Etopophos®
02 Sep 2019 //
BUSINESSWIRE
H2-Pharma and Cheplapharm launch of Etopophos Injection
11 Jul 2019 //
THE PHARMALETTER
AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada
03 Dec 2018 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.